383 related articles for article (PubMed ID: 12804501)
1. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.
Carless PA; Henry DA; Anthony DM
Cochrane Database Syst Rev; 2003; 2003(2):CD004171. PubMed ID: 12804501
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion.
Carless PA; Anthony DM; Henry DA
Br J Surg; 2002 Jun; 89(6):695-703. PubMed ID: 12027978
[TBL] [Abstract][Full Text] [Related]
3. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.
Carless PA; Rubens FD; Anthony DM; O'Connell D; Henry DA
Cochrane Database Syst Rev; 2003; (2):CD004172. PubMed ID: 12804502
[TBL] [Abstract][Full Text] [Related]
4. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell DL; Fergusson DA
Cochrane Database Syst Rev; 2003; (4):CD001888. PubMed ID: 14583940
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2004; (1):CD001884. PubMed ID: 14973974
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin for minimising perioperative allogeneic blood transfusion.
Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2001; (2):CD001884. PubMed ID: 11406016
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.
Carless PA; Rubens FD; Anthony DM; O'Connell D; Henry DA
Cochrane Database Syst Rev; 2011 Mar; (3):CD004172. PubMed ID: 21412885
[TBL] [Abstract][Full Text] [Related]
8. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'connell DL; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2006 Oct; (4):CD001888. PubMed ID: 17054147
[TBL] [Abstract][Full Text] [Related]
9. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell D; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2010 Mar; (3):CD001888. PubMed ID: 20238316
[TBL] [Abstract][Full Text] [Related]
10. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell D; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD001888. PubMed ID: 20393932
[TBL] [Abstract][Full Text] [Related]
11. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
[TBL] [Abstract][Full Text] [Related]
12. Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.
Beverly A; Ong G; Kimber C; Sandercock J; Dorée C; Welton NJ; Wicks P; Estcourt LJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013649. PubMed ID: 36800489
[TBL] [Abstract][Full Text] [Related]
13. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2001; (1):CD001886. PubMed ID: 11279735
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Forgie MA; Wells PS; Fergusson D
Cochrane Database Syst Rev; 2002; 2001(2):CD003602. PubMed ID: 12076491
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
[TBL] [Abstract][Full Text] [Related]
16. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
Hill SR; Carless PA; Henry DA; Carson JL; Hebert PC; McClelland DB; Henderson KM
Cochrane Database Syst Rev; 2002; (2):CD002042. PubMed ID: 12076437
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
[TBL] [Abstract][Full Text] [Related]
18. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
Carless PA; Henry DA; Carson JL; Hebert PP; McClelland B; Ker K
Cochrane Database Syst Rev; 2010 Oct; (10):CD002042. PubMed ID: 20927728
[TBL] [Abstract][Full Text] [Related]
19. Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study.
Massin P; Scemama C; Jeanrot C; Boyer P
Orthop Traumatol Surg Res; 2012 Apr; 98(2):180-5. PubMed ID: 22405589
[TBL] [Abstract][Full Text] [Related]
20. [Fibrin sealants can reduce the use of blood transfusions in surgery. A status article based on the Cochrane analysis "Fibrin sealant use for minimising peri-operative blood transfusion"].
Kjaergård HK
Ugeskr Laeger; 2004 May; 166(23):2235-7. PubMed ID: 15487519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
